Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-10 | New | $1,000,000 | $1,000,000 | Equity Only | 06b | SEC link |
| 2025-04-14 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
| 2025-01-22 | New | $499,999 | $499,999 | Equity Only | 06b | SEC link |
| 2024-10-21 | New | $7,200,000 | $7,200,000 | Equity Only | 06b | SEC link |
| 2024-07-15 | New | $786,660 | $786,660 | Equity Only | 06b | SEC link |
| 2024-04-03 | New | $1,750,000 | $1,750,000 | Equity Only | 06b | SEC link |
| 2022-12-21 | New | $10,000,000 | $10,000,000 | Equity Only | 06b | SEC link |
| 2022-10-14 | New | $4,000,000 | $4,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Florence Allouche Aknin | Director |
| Florence Allouche Aknin | Director |
| George Apostol | Executive |
| Claudio L.A. Basseti | Director |
| Claudio L. A. Bassetti | Director |
| Nicole Fernandez Mc Govern | Executive |
| Audrey Greenberg | Director |
| Ronald Hafner | Director |
| Chad Hellmann | Executive |
| Eric Konofal | Executive |
| Myoung Ok Kwon | Director |
| Stig Lokke Pedersen | Director |
| Gian Marco Rinaldi | Director |
| Gian Marco Rinaldi De La Cruz | Director |
| Olivier Samuel | Director |
| Elena Thyen Pighin | Executive |
| Anthony Walsh | Director |
| Alexander Zwyer | Director, Executive |